Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer

Publikation

Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer

Wissenschaftlicher Artikel/Review - 01.05.1999

Pagani O, Riva A, Graffeo R, Zimatore M, Zampino G, Bauer J, Borner M, Hess Dagmar, Thürlimann Beat, Buonadonna A, Crivellari D, Martinelli G, Sessa C, Goldhirsch A

Pagani, O

Sessa, C

Martinelli, G

Crivellari, D

Buonadonna, A

Thürlimann, Beat

259

Hess, Dagmar

Oberärztin mbF
Medizinische Onkologie und Hämatologie · Dept. I

Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer

Pagani, O

Sessa, C

Martinelli, G

Crivellari, D

Buonadonna, A

Thürlimann, Beat

Hess, Dagmar

Borner, M

Bauer, J

Zampino, G

Zimatore, M

Graffeo, R

Riva, A

Goldhirsch, A